IMBRIA PHARMACEUTICALS, INC.
Profile
Company Names
IMBRIA PHARMACEUTICALS, INC.
Addresses
265 FRANKLIN STREET, SUITE #1702, BOSTON, MA 02110
17511 LOS MORROS, RANCHO SANTA FE, CA 92067
Phone Numbers
858-413-7899
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$147,680,744.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-03-10
$66,695,817.00
$144,195,814.00
$77,499,997.00
Equity
2
2020-06-22
$40,734,932.00
$80,734,932.00
$40,000,000.00
Equity
1
2018-07-02
$40,249,995.00
$40,249,995.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PIETER
BOELHOUWER
DIRECTOR
KEN
HORNE
DIRECTOR
ANDREW
LEVIN
DIRECTOR
IMMUNETICS, INC.
| ARVINAS HOLDING COMPANY, LLC
| SYNTHORX, INC.
| CLEANBREAK, INC.
| CLEAR CREEK BIO, INC.
| IMBRIA PHARMACEUTICALS, INC.
| ELIEM THERAPEUTICS, INC.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| CYTEK BIOSCIENCES, INC.
| METAGENOMI TECHNOLOGIES, LLC
| LUSARIS THERAPEUTICS, INC.
| SUPERLUMINAL MEDICINES, INC.
| NAVIGATOR MEDICINES, INC.
| AKTIS ONCOLOGY, INC.
| PAHR THERAPEUTICS, INC.
| LONESTAR MEDICINES, INC.
| SOLSTICE ONCOLOGY, INC.
| SLATE MEDICINES, INC.
| CLIMB BIO, INC.
REBECCA
LUSE
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-03-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-03-10
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-06-22
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

